Back to Results

BioCorRx Inc (BICX)

BioCorRx Inc. is a healthcare company listed on OTC Markets under the ticker BICX. Through its subsidiaries, the company develops and provides treatment programs in the United States for substance abuse and related disorders. Its offerings include Beat Addiction Recovery, a substance use disorder recovery program that combines cognitive behavioral therapy modules, peer support delivered through a mobile application, and medication prescribed by an independent physician. BioCorRx also provides UnCraveRx, a medication-assisted weight loss program with access to concierge on-demand wellness specialists. In addition, the company is developing several naltrexone-based product candidates, including BICX101, BICX102, and BICX104. BioCorRx licenses and distributes its programs to healthcare providers and licensed healthcare professionals. The company, founded in 2009 and based in Anaheim, California, adopted its current name in 2014.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-BICX
$0.23
13.0% Upside
Fair
Not available
Not available
Fair
0.0%
November 17, 2026
10.4x
6.049 M
8.838 M
25.9%
40.8%
-186.3
71.9%
Valuation • Fair Value

BioCorRx Inc (OTC-BICX) Fair Value by Valuation Model

Review the available estimates for BioCorRx Inc (OTC-BICX), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.23

Estimated upside of 13.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.23

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for BioCorRx Inc (OTC-BICX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for BioCorRx Inc (OTC-BICX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

651.145 K

Current operating scale indicator.

Revenue Forecast

971.85 K

Forward revenue estimate.

EBITDA

-5.078 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review BioCorRx Inc (OTC-BICX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for BioCorRx Inc (OTC-BICX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-4.60

No elevated caution signal from this screen.

Altman Z-Score

-186.3

Lower score that deserves closer risk review.

FCF / Net Income

71.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for BioCorRx Inc (OTC-BICX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for BioCorRx Inc (OTC-BICX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 17, 2026

Days to Earnings

56

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for BioCorRx Inc (OTC-BICX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for BioCorRx Inc (OTC-BICX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for BioCorRx Inc (OTC-BICX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for BioCorRx Inc (OTC-BICX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for BioCorRx Inc (OTC-BICX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for BioCorRx Inc (OTC-BICX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

BioCorRx Inc (OTC-BICX) Stock FAQ

Data-supported answers about BioCorRx Inc (OTC-BICX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.23
Estimated upside 13.0%
Valuation Rating
Undervalued
Estimated upside of 13.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for BioCorRx Inc (OTC-BICX) is $0.23. This implies an estimated upside of 13.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 13.0% versus the current market price.

The current financial health read for BioCorRx Inc (OTC-BICX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for BioCorRx Inc (OTC-BICX) is November 17, 2026.

The latest available data indicates no current dividend yield for BioCorRx Inc (OTC-BICX).

The current market capitalization listed for BioCorRx Inc is 6.049 M.

The current enterprise value listed for BioCorRx Inc is 8.838 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for BioCorRx Inc is OTC-BICX, and the stock is listed on OTC Markets.

BioCorRx Inc (OTC-BICX) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for BioCorRx Inc is 25.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for BioCorRx Inc is 40.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B